MAPT and Cognitive impairment: The preclinical data showed that GV-971 remodels the gut microbiota and the associated accumulation of phenylalanine and isoleucine, reduces microglial activation, immune responses, Aβ plaque deposition, and tau phosphorylation in the brain, and improves the cognitive impairment in 5xFAD mice [261].